Peng Huang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 29

Top Topics

Mass Spectrometry

Top Venues

Nature communications

Cell death and differentiation

Nature reviews. Drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Yongjie Deng, Yao Yao, Yanni Wang, Tiantian Yu, Wenhao Cai, Dingli Zhou, Feng Yin, Wan-Li Liu, Yuying Liu, Chuanbo Xie, Jian Guan, Yumin Hu, Peng Huang, Weizhong Li
An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles. Nature communications 15 (1) (2024)
Ping Feng, Ying Wang, Na Liu, Yanming Chen, Yujun Hu, Zilu Huang, Ya Liu, Shuohan Zheng, Tongchao Jiang, Xiang Xiao, Wei Dai, Peng Huang, Yunfei Xia
High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma. Cell death and differentiation 31 (5) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Ping Feng, Ying Wang, Na Liu, Yanming Chen, Yujun Hu, Zilu Huang, Ya Liu, Shuohan Zheng, Tongchao Jiang, Xiang Xiao, Wei Dai, Peng Huang, Yunfei Xia
High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma. Cell death and differentiation 31 (5) (2024)
Ping Feng, Ying Wang, Na Liu, Yanming Chen, Yujun Hu, Zilu Huang, Ya Liu, Shuohan Zheng, Tongchao Jiang, Xiang Xiao, Wei Dai, Peng Huang, Yunfei Xia
High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma. Cell death and differentiation 31 (5) (2024)
Ping Feng, Ying Wang, Na Liu, Yanming Chen, Yujun Hu, Zilu Huang, Ya Liu, Shuohan Zheng, Tongchao Jiang, Xiang Xiao, Wei Dai, Peng Huang, Yunfei Xia
High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma. Cell death and differentiation 31 (5) (2024)
Yongjie Deng, Yao Yao, Yanni Wang, Tiantian Yu, Wenhao Cai, Dingli Zhou, Feng Yin, Wan-Li Liu, Yuying Liu, Chuanbo Xie, Jian Guan, Yumin Hu, Peng Huang, Weizhong Li
An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Ping Feng, Ying Wang, Na Liu, Yanming Chen, Yujun Hu, Zilu Huang, Ya Liu, Shuohan Zheng, Tongchao Jiang, Xiang Xiao, Wei Dai, Peng Huang, Yunfei Xia
High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma. Cell death and differentiation (2024)
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham, Peng Huang
Targeting ROS in cancer: rationale and strategies. Nature reviews. Drug discovery 23 (8) (2024)
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham, Peng Huang
Targeting ROS in cancer: rationale and strategies. Nature reviews. Drug discovery (2024)
Yao Yao, Xueping Wang, Jian Guan, Chuanbo Xie, Hui Zhang, Jing Yang, Yao Luo, Lili Chen, Mingyue Zhao, Bitao Huo, Tiantian Yu, Wenhua Lu, Qiao Liu, Hongli Du, Yuying Liu, Peng Huang, Tiangang Luan, Wan-Li Liu, Yumin Hu
Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera. Nature communications 14 (1) (2023)
He Li, Jiang-Jiang Li, Wenhua Lu, Jing Yang, Yunfei Xia, Peng Huang
Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines 11 (2) (2023)
He Li, Jiang-Jiang Li, Wenhua Lu, Jing Yang, Yunfei Xia, Peng Huang
Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines 11 (2) (2023)
Yao Yao, Xueping Wang, Jian Guan, Chuanbo Xie, Hui Zhang, Jing Yang, Yao Luo, Lili Chen, Mingyue Zhao, Bitao Huo, Tiantian Yu, Wenhua Lu, Qiao Liu, Hongli Du, Yuying Liu, Peng Huang, Tiangang Luan, Wan-Li Liu, Yumin Hu
Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera. Nature communications 14 (1) (2023)
Yao Yao, Xueping Wang, Jian Guan, Chuanbo Xie, Hui Zhang, Jing Yang, Yao Luo, Lili Chen, Mingyue Zhao, Bitao Huo, Tiantian Yu, Wenhua Lu, Qiao Liu, Hongli Du, Yuying Liu, Peng Huang, Tiangang Luan, Wan-Li Liu, Yumin Hu
Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera. Nature communications 14 (1) (2023)
He Li, Jiang-Jiang Li, Wenhua Lu, Jing Yang, Yunfei Xia, Peng Huang
Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines 11 (2) (2023)
Yao Yao, Xueping Wang, Jian Guan, Chuanbo Xie, Hui Zhang, Jing Yang, Yao Luo, Lili Chen, Mingyue Zhao, Bitao Huo, Tiantian Yu, Wenhua Lu, Qiao Liu, Hongli Du, Yuying Liu, Peng Huang, Tiangang Luan, Wan-Li Liu, Yumin Hu
Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera. Nature communications 14 (1) (2023)
Yao Yao, Xueping Wang, Jian Guan, Chuanbo Xie, Hui Zhang, Jing Yang, Yao Luo, Lili Chen, Mingyue Zhao, Bitao Huo, Tiantian Yu, Wenhua Lu, Qiao Liu, Hongli Du, Yuying Liu, Peng Huang, Tiangang Luan, Wan-Li Liu, Yumin Hu
Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera. Nature communications 14 (1) (2023)
Qingbin Cui, Wenwen Ding, Pan-Pan Liu, Bingling Luo, Jing Yang, Wenhua Lu, Yumin Hu, Peng Huang, Shijun Wen
Developing Bi-Gold Compound BGC2a to Target Mitochondria for the Elimination of Cancer Cells. International journal of molecular sciences 23 (20) (2022)
Peiting Zeng, Wenhua Lu, Jingyu Tian, Shuang Qiao, Jiangjiang Li, Christophe Glorieux, Shijun Wen, Hui Zhang, Yiqing Li, Peng Huang
Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy. Journal of hematology & oncology 15 (1) (2022)
Mingquan Zhang, Rong Xiang, Christophe Glorieux, Peng Huang
PLA2G2A Phospholipase Promotes Fatty Acid Synthesis and Energy Metabolism in Pancreatic Cancer Cells with K-ras Mutation. International journal of molecular sciences 23 (19) (2022)
Shihua Liu, Ya Qiu, Rong Xiang, Peng Huang
Characterization of H 2 O 2 -Induced Alterations in Global Transcription of mRNA and lncRNA. Antioxidants (Basel, Switzerland) 11 (3) (2022)
Wenqiang Xie, Juan Fang, Zhongyan Shan, Junyi Guo, Yuan Liao, Zhaolei Zou, Jun Wang, Shuqiong Wen, Lisa Yang, Yanshu Zhang, Huanzi Lu, Hang Zhao, Dong-Ming Kuang, Peng Huang, Qian-Ming Chen, Zhi Wang
Regulation of autoimmune disease progression by Pik3ip1 through metabolic reprogramming in T cells and therapeutic implications. Science advances 8 (39) (2022)
Shuang Qiao, Wenhua Lu, Christophe Glorieux, Jiangjiang Li, Peiting Zeng, Ning Meng, Huiqin Zhang, Shijun Wen, Peng Huang
Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer. Oncogene 40 (39) (2021)
Feifei Xu, Zining Wang, Hongxia Zhang, Jiemin Chen, Xiaojuan Wang, Lei Cui, Chunyuan Xie, Mengyun Li, Fang Wang, Penghui Zhou, Jinyun Liu, Peng Huang, Xiaodong Xia, Xiaojun Xia
Mevalonate Blockade in Cancer Cells Triggers CLEC9A+ Dendritic Cell-Mediated Antitumor Immunity. Cancer research 81 (17) (2021)
Christophe Glorieux, Xiaojun Xia, Peng Huang
The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer. Cancers 13 (17) (2021)